Syngene International Gets ‘Buy’ Call For 24% Potential Upside, Recommended By ICICI Securities


ICICI Securities has recently published a report on Syngene International Limited with a ‘buy’ for a target price of Rs 710 apiece. The brokerage sees a potential 24 per cent gain. Syngene is contract research, development and manufacturing organisation catering mainly